A detailed history of Larson Financial Group LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Larson Financial Group LLC holds 47 shares of FLGT stock, worth $839. This represents 0.0% of its overall portfolio holdings.

Number of Shares
47
Previous 47 -0.0%
Holding current value
$839
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$19.09 - $22.57 $1,909 - $2,257
-100 Reduced 68.03%
47 $0
Q1 2024

May 03, 2024

BUY
$21.55 - $29.29 $2,155 - $2,929
100 Added 212.77%
147 $3,000
Q4 2021

Feb 03, 2022

BUY
$77.3 - $105.0 $3,633 - $4,935
47 New
47 $5,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $541M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Larson Financial Group LLC Portfolio

Follow Larson Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Larson Financial Group LLC with notifications on news.